Pediatric Brain Tumors: What Every Parent Should Know
Raj and Meera always felt blessed by their baby boy, Aarav, who seemed to radiate happiness. His giggles and endless smiles made every day a joy for them. Strangers in the supermarket often remarked on how cheerful he seemed, making Meera and Raj proud of their bubbly little boy. One day, while grocery shopping, they bumped into Dr. Gupta, an old acquaintance who happened to be a pediatrician.
Dr. Gupta admired Aarav's bright smiles but seemed to study him a bit too intently. Politely, she asked if they had noticed any other unusual behavior.
Raj and Meera were taken aback when Dr. Gupta gently suggested they visit a doctor, not out of concern for Aarav’s happiness, but because she had noticed something off about his behavior. Dr. Gupta made it clear that she didn’t want to worry them, but from her medical perspective, Aarav’s constant, almost involuntary smiling could be more than just happiness. "Sometimes, things aren't what they seem," she said kindly, "and it wouldn’t hurt to rule out any underlying issues, just to be safe."
Despite their initial shock and fear, Meera and Raj took her advice seriously. Little did they know that Dr. Gupta’s careful observation would lead to a life-changing diagnosis. Aarav was eventually diagnosed with a benign brain tumor, which had been affecting certain parts of his brain responsible for facial expressions. Though it was a difficult journey, catching the tumor early helped them get Aarav the care he needed. Raj and Meera learned the importance of trusting their instincts but also listening when a medical professional raises a red flag, no matter how subtle it may seem.
Pediatric brain tumors are abnormal growths of cells that begin in or around the brain in children. These growths, called tumors, can press on nearby areas of the brain, which can lead to a range of symptoms, including headaches, nausea, and in some cases, more subtle changes like irritability or vision problems. While any brain tumor diagnosis can be overwhelming, it’s important for parents to understand the different types of brain tumors and the treatment options available for their children.
Brain tumors in children vary widely in terms of growth rate and severity. Some tumors are fast-growing and aggressive, while others grow slowly over time. Tumors can also be classified as cancerous (malignant) or noncancerous (benign). However, it’s important to note that even benign tumors can cause significant health issues if they grow large enough or are located in sensitive areas of the brain.
The type of brain tumor, along with its location and whether it has spread beyond the brain, plays a key role in determining the best treatment plan for a child.
Other factors that healthcare providers consider when planning treatment include the child’s age, overall health, and the size of the tumor. Pediatric brain tumors require specialized care, as the treatments for children are often different from those used for adults. This is why it’s essential to seek medical advice from a center that has experience treating pediatric brain tumors, where the team will be better equipped to manage the unique needs of children.
The signs and symptoms of pediatric brain tumors can vary depending on the size and location of the tumor, as well as how quickly the tumor is growing. Some common signs to watch for include frequent headaches, which may become progressively worse. For children who are too young to communicate, parents might notice increased irritability as a sign of discomfort. Another common symptom is nausea and vomiting, which can occur without any other signs of illness.
Vision problems are also a red flag. Children may develop double vision or other changes in how they see. Non-verbal children may squint, rub their eyes frequently, or even cover one eye when trying to focus on something. Other symptoms include balance problems, confusion, and changes in personality or behavior. Parents may also notice their child struggling to walk, slurring their speech, or having trouble swallowing.
In babies, signs of a brain tumor can be even more subtle. A fuller-than-usual soft spot on the head or abnormal eye movements can be early indicators. Seizures, especially if they occur in a child who has never had one before, should also prompt immediate medical attention.
It’s important for parents to act promptly if they observe any of the warning signs of a brain tumor. Symptoms like frequent headaches, vomiting, vision changes, or unexplained irritability should not be ignored. If a child is showing any of these symptoms, parents should make an appointment with their pediatrician or another healthcare provider. Early detection and treatment can make a significant difference in a child’s prognosis and quality of life.
While the idea of a brain tumor is frightening, it’s important to remember that treatment options have advanced significantly. With early diagnosis and a personalized treatment plan, many children with brain tumors can lead full and healthy lives.
As parents, it’s crucial to stay informed and attentive to any changes in your child’s health, as early intervention is key in managing pediatric brain tumors effectively.
Credits: Canva
Weight-loss jabs, or GLP-1 receptor agonists, have provided many people with results that diets alone could not achieve. For those struggling with constant cravings, these medications have quieted the persistent “food noise” that often drives overeating. They have transformed not only body shapes but also self-confidence and daily habits.
Yet questions remain: can people safely stop taking these drugs, and what happens to the body when they do? These are still largely unknown, as the drugs are relatively new. GLP-1s mimic a natural hormone that controls hunger, but the long-term effects are only beginning to be understood. Additionally, for the estimated 1.5 million people in the UK paying privately for these injections, maintaining treatment can be costly.
Two women, Tanya and Ellen, share their personal experiences with the BBC on weight-loss jabs and what life was like when they attempted to stop.
Tanya, a sales manager in the fitness industry, initially started taking Wegovy to challenge her own perceptions about weight and authority. She often felt overlooked or undervalued because of her size, and hoped that losing weight would change how others treated her, as per BBC.
Early in treatment, Tanya experienced side effects including nausea, headaches, sleep issues, and hair loss, which she describes as clumps coming out. Despite this, she steadily lost weight—six stone (38 kg) over 18 months—and the injections quieted the relentless urge to eat.
However, every time she tried to stop, her appetite surged within days, leaving her horrified at her own eating. Now, Tanya continues the medication, feeling it has become essential to maintaining her weight and the confidence it brings.
Wegovy’s manufacturer, Novo Nordisk, stresses that treatment decisions should be made with medical guidance and that side effects must be considered. Lifestyle GP Dr. Hussain Al-Zubaidi likens stopping GLP-1s abruptly to being hit by a “tsunami” of hunger.
Research shows that within one to three years of stopping these medications, people can regain 60–80% of the weight they lost. This highlights how these drugs work not just by reducing appetite temporarily but by fundamentally altering hunger cues.
Ellen turned to Mounjaro after reaching a critical point in her life. Her weight had put her at risk during surgery, and emotional binge eating dominated her daily habits. Once on the medication, Ellen noticed her compulsive eating completely stopped.
Over 16 weeks, she lost 3 st 7 lb (22 kg) and began tapering off the injections over six weeks. She focused on developing a healthier relationship with food, creating balanced meals, and incorporating exercise into her routine. Despite some weight creep after stopping, she has since lost a total of 51 kg and now feels confident her habits are sustainable.
Dr. Al-Zubaidi emphasizes that exiting GLP-1 treatment safely requires guidance and long-term support. NICE recommends at least a year of tailored advice after stopping injections to help individuals maintain their weight and prevent relapse, as per BBC.
For patients paying privately, such structured support may not always be available, increasing the risk of regaining weight. Lifestyle, mindset, and environmental factors play a significant role in long-term outcomes.
Tanya has chosen to continue with her medication, aware of the pros and cons, while Ellen has closed that chapter and built a sustainable routine for life after Mounjaro.
Weight-loss jabs can dramatically change appetite and body weight, but stopping them can be challenging. The transition off these drugs requires careful planning, support, and lifestyle adjustments. As Tanya and Ellen’s experiences show, the journey varies by individual, and long-term strategies are essential to maintaining health and weight loss results.
Eli Lilly, the manufacturer of Mounjaro, states that patient safety is its top priority and that it continually monitors and reports information on treatment outcomes to regulators and prescribers.
Credits: Canva
Flu Symptoms: Seasonal infections are spreading across the United States just as the holiday travel rush gets underway, worrying health officials about fresh spikes during family get-togethers. Flu and norovirus cases are rising in several states, while COVID-19 continues to circulate at lower but consistent levels. Together, these illnesses are adding strain on hospitals as millions of people plan to travel in the days ahead.
“Super flu” is not a clinical term, but it is often used to describe a flu season that feels more aggressive or spreads faster than usual. This is typically linked to a dominant strain of influenza A. The current surge is being driven by a mutated influenza A strain known as H3N2 subclade K. Health officials say this strain has become the leading flu variant in the US, accounting for roughly 89 percent of H3N2 samples analysed since late September, according to genetic sequencing data from the Centers for Disease Control and Prevention (CDC).
This variant emerged after the 2025–26 flu vaccine was formulated, meaning the vaccine may not be as closely matched as in earlier seasons. While the shot still offers protection against severe disease, experts note that the mismatch could allow the virus to spread more easily.
The symptoms seen in the current flu wave are largely familiar. People may develop fever, chills, extreme tiredness, cough, and body aches. Doctors, however, caution that the wider spread could result in more serious cases, particularly among people who are at higher risk.
CDC estimates indicate that the US has already seen about 4.6 million flu cases this season, along with nearly 49,000 hospital admissions and around 1,900 deaths. Flu activity increased sharply in mid-December, with test positivity jumping from 8.1 percent to 14.3 percent within a single week.
Doctors recommend staying home when feeling unwell, washing hands often, especially to limit norovirus spread, and considering vaccination against flu and COVID-19. Even when the strain match is not ideal, experts stress that vaccines remain crucial in reducing the risk of severe illness, hospitalisation, and death.
In terms of how easily it spreads, it behaves much like regular flu, which is known to be highly contagious.
Someone with flu can pass on the virus from around one day before symptoms appear and continue to be contagious for five to seven days after becoming sick. Children, older adults, and those with weakened immune systems may remain infectious for a longer period.
The virus mainly spreads through respiratory droplets released when an infected person coughs, sneezes, speaks, or breathes near others. It can also spread through contact with contaminated surfaces, followed by touching the mouth, nose, or eyes. Crowded indoor settings, poor airflow, and close contact make transmission far more likely, which explains why flu spreads quickly during peak season.
What makes a so-called “super flu” seem more contagious is not a new way of spreading, but higher case numbers, quicker community transmission, and stronger symptoms, all of which increase coughing, fever, and the amount of virus released.
Credits: Canva
The NHS has urged people using a commonly prescribed medication to seek urgent medical advice if they notice any of three specific symptoms. These are linked to some of the more serious complications associated with dapagliflozin. Sold under the brand name Forxiga, dapagliflozin is mainly used to treat type 2 diabetes. It is also prescribed for people with heart failure and chronic kidney disease. While exact figures on how many prescriptions are issued each year in the UK are not publicly available, the drug is among the costliest for the health service, with NHS spending estimated at around £300 million a year in England alone.
Dapagliflozin belongs to a group of medicines known as SGLT2 inhibitors. It works by helping the kidneys remove excess glucose from the body through urine, which lowers blood sugar levels. Beyond diabetes, the drug has been shown to reduce the risk of hospitalisation in people with heart failure and slow the progression of chronic kidney disease. It may be prescribed on its own or alongside other treatments, depending on a patient’s condition and overall health.
Dapagliflozin can also be prescribed in combination with other diabetes medicines. These include Xigduo, which combines dapagliflozin with metformin, and Qtern, which pairs dapagliflozin with saxagliptin.
However, the NHS warns on its website that, “like all medicines,” dapagliflozin can cause side effects in some people. Patients are advised to “call your doctor or call 111 now” if they experience:
These reactions are classed as rare, affecting fewer than one in 10,000 people. More common side effects occur in over one in 100 users. The NHS says: “They’re usually mild and do not last long. There are things you can do to help cope with them.”
The NHS lists the following as more frequent side effects:
Taking dapagliflozin alongside other diabetes medicines, such as insulin or sulfonylureas like gliclazide, can sometimes cause blood sugar levels to drop too low. Some people may also develop diabetic ketoacidosis (DKA).
DKA happens when the body lacks enough insulin and harmful acids, known as ketones, build up in the blood. Warning signs can include nausea or vomiting, extreme thirst, confusion or severe tiredness, stomach pain, fruity-smelling breath, and fast or deep breathing. The NHS notes that symptoms usually develop within 24 hours, though they can appear more quickly.
Patients are taught how to monitor their blood sugar and ketone levels and what steps to take if symptoms appear. Emergency services should be contacted immediately by calling 999 if a person experiences a severe allergic reaction, known as anaphylaxis, after taking dapagliflozin.
© 2024 Bennett, Coleman & Company Limited